ClinicalTrials.Veeva

Menu
Amnova Clinical Research | Irvine, CA logo

Amnova Clinical Research | Irvine, CA

Research site

Site insights

Top conditions

Top treatments

BPN14770
Ecopipam Hydrochloride
JZP258-407
ZYN002
Cannabidiol

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Maggie Wang

Verified by this site

Active trials

5 of 8 total trials

A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome

This is a 2-part study, with each part having a unique set of objectives for male adolescents aged 9 to \< 18 years with fragile X syndrome (FXS). Pa...

Active, not recruiting
Fragile X Syndrome
Drug: zatolmilast
Drug: Placebo

This is a 4-year, open-label extension (OLE) study for subjects completing one of two double-blind clinical trials with BPN14770, Study BPN14770-CNS-...

Invitation-only
Fragile X Syndrome
Drug: Zatolmilast/ BPN14770

This is a randomized, double-blind, placebo-controlled, multiple-center study, to assess the efficacy and safety of Cannabidiol administered as ZYN00...

Active, not recruiting
Fragile X Syndrome
Drug: Placebo
Drug: ZYN002 - transdermal gel

The objective of this clinical study is to evaluate the accuracy of the Smart Mask V1 System (herein 'Smart Mask') in measuring sleep stages-Stage N1...

Not yet enrolling
Sleep Disordered Breathing (SDB)
Sleep Apnea
Device: EnsoSleep
Diagnostic Test: Polysomnography

ZYN002 is a pharmaceutically manufactured Cannabidiol that is developed as a clear gel that can be applied to the skin (called transdermal delivery)....

Invitation-only
Fragile X Syndrome
Drug: ZYN002 - Cannabidiol Transdermal Gel

Trial sponsors

T
Z
E
Jazz Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems